Expected Insurance Coverage and Savings Programs When retatrutide commercially launches, the out-of-pocket cost for patients will depend heavily on insurance coverage and manufacturer assistance programs
(28) There were no statistically significant differences in amputation risk between GLP-1s, SGLT-2 inhibitors, DPP4-Is, and all other agents
On average, participants had already reduced their body mass index (BMI) from 30, which is the level considered obese, to 25.2, which falls in the overweight range
As you can see from the title, the researchers found disparate results when they tested obese adolescents versus obese adults
doi: 10.1016/j.autrev.2010.07.016 87
First, these agents promote clinically meaningful weight loss